If you are new to domains and looking to buy, sell and learn about domains then you have come to the right place. DNForum is the largest domain name community on the internet and continues to grow every day. There are over 105,000 domainers on DNForum doing everything from buying domains, selling domains, learning about domains and discussing domains. Take a minute and Register.
Register Today on DNForum IT'S FREE!Story here:
http://www.webwire.com/ViewPressRel.asp?aId=5437
You'll notice the site uses AdSense. Typically these sites lose UDRPs.
A settlement doesn't create a legal precedent, but it's surprising that the drug company caved.
I expect that the use of the disclaimer text is sure to come up in future UDRPs.
George Kirikos
Home Page
Interesting. A fair result I think for 'fair use' indeed.
The argument a TM holder could have used, potentially, is that it's a "sham" site, i.e. essentially "made for advertising", instead of a legit news site.
Although, in this particular case, the principals behind the site appear to have some legitimacy. See:
http://www.acompliareport.com/About.htm
(i.e. doctors with medical background, others with publishing background)
If it was just an Average Joe doing it, or the typical "scraper" "made for Adsense" site, the drug company probably would not settle.
George Kirikos
Home Page
To wit, the erstwhile www.paypalsucks.com. No real advertising to speak of, but a legitimate commentary.
I say kudos to Sanofi-Aventis for being reasonable on this one, especially for
realizing how beneficial this site can be to them. The other side is darn lucky.
Vidi, Vici, Veni!
Bookmarks